PCRX Pacira BioSciences, Inc.: institutional ownership and insider trading
270 funds reported holding $1.26B of Pacira BioSciences, Inc. in their latest 13F filings; in Q2 2026 funds net bought $4.25M, with 35 new positions and 23 funds selling out; over the last 12 months insiders bought $0 and sold $2.75M on the open market.
Famous investors holding PCRX
- Renaissance Technologies (Renaissance Technologies): $44.0M, 0.1% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $49.5M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $18.4M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $5.97M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $4.11M, 0.0% of the portfolio
Largest institutional holders of PCRX
- BlackRock, Inc. (BLK) — $170M
- VANGUARD GROUP INC — $125M
- Doma Perpetual Capital Management LLC — $70.5M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $61.0M
- DIMENSIONAL FUND ADVISORS LP — $53.4M
- STATE STREET CORP (STT, STT-PG) — $52.3M
- D. E. Shaw & Co., Inc. — $49.5M
- RENAISSANCE TECHNOLOGIES LLC — $44.0M
- VANGUARD CAPITAL MANAGEMENT LLC — $42.9M
- GOLDMAN SACHS GROUP INC (GS, GSCE, GS-PA, GS-PC, GS-PD) — $38.7M
Recent PCRX insider trades
- Oct 8, 2026: Riker Lauren sold 6,000 shares ($218K)
- Aug 17, 2026: Slonin Jonathan sold 3,040 shares ($70.6K)
- Jun 11, 2026: Riker Lauren sold 6,115 shares ($144K)
- Jun 4, 2026: Williams Kristen sold 10,259 shares ($228K)
5%+ owners
- Vanguard Portfolio Management: 6.4% (Schedule 13G, filed May 1, 2026)
- STATE STREET CORPORATION: 5.2% (Schedule 13G, filed Aug 7, 2026)
- Vanguard Capital Management: 5.2% (Schedule 13G, filed May 1, 2026)
- Dimensional Fund Advisors LP: 5.1% (Schedule 13G, filed Apr 9, 2026)